Call us today: +44 (0) 20 3551 6634
People with schizophrenia may have a lower suicide rate if they take antidepressants, a new study has found.
International healthcare providers might alter the prescriptions they write out for mentally-ill expatriates following the research, which involved the analysis of 2,558 Finnish people who had a recent diagnosis of schizophrenia.
Scientists analysed the participants for an average of four years from their initial admission into a hospital and determined what their leading causes of death were.
Furthermore, the researchers accessed Finnish registers to understand the effects different medications had on an individual's mortality risks.
The study, which was published in the Archives of General Psychiatry and led by Karolinska Institutet's Department of Clinical Neuroscience, found 160 research participants died during the investigation.
A total of 57 of these died of external causes such as violent crimes, poisoning or drowning, with 35 of these deaths believed to be cases of people taking their own lives.
The two main causes of death among the subjects in the research were cardiovascular disease and suicide.
However, those who were taking benzodiazepines had a 91 per cent higher chance of early death than those who did not, with suicide overwhelmingly the most common cause of a fatality among this group.
Throughout the periods in which antidepressant drugs were utilised, the risk of mortality was 43 per cent lower than during those times when they were not, with the suicide risk cut by 85 per cent.
Multiple prescriptions of antipsychotics were found to have no significant impact on mortality rates.
People who had taken benzodiazepines for over four weeks were the most likely to commit suicide.
According to the UK's National Health Service, antipsychotics are generally advised as the initial medicine to treat an acute schizophrenic episode.
"We weren't aware that the beneficial effects of anti-depressives were so powerful," professor of clinical psychiatry at the research institute Jari Tiihonen said.
"The increased suicide risk for patients with long-standing benzodiazepine use may be partly attributable to the possible development of withdrawal symptoms when the drugs run out," he suggested.
Expatriate Healthcare specialise in providing international health insurance. Make sure you're protected. © Expatriate Healthcare
Expatriate Group.Delmon House,36-38 Church Road,Burgess Hill,West Sussex,RH15 9AE
Registered Address.35 Ballards Lane,London,N3 1XW
Tel: +44 (0)20 3551 6634Fax: +44 (0)870 428 5141Email: firstname.lastname@example.org
Short Term Healthcare Insurance
Travel Medical Insurance One Way Travel Insurance Single Trip Travel Insurance Annual Multi-Trip Travel Insurance Non UK Resident Travel Insurance Business Travel Insurance
About Us Useful Links Leave a Review Our Awards The Press Room Satisfaction Survey Downloads Legal Notice Underwriters Hospital List
Emergency Assistance information Short-Term Healthcare Working Abroad Insurance Thailand Health Insurance
Register as an Intermediary Opportunities for Brokers
Expatriate Group & Expatriate Healthcare are trading styles of Strategic Insurance Services Limited who is authorised and regulated by the Financial Conduct Authority (FCA). FCA Firm reference Number is 307133. Strategic Insurance Services Limited is authorised to carry on Regulated Activities in accordance with the permissions granted by the FCA under PART IV of the Financial Services and Markets ACT 2000.